Mohammad Hassan Nazaran

Harnessing nanomedicine for breast cancer therapy through the immunomodulatory activity of BCc1

Although BCc1 represents a novel nanochelating-based nanomedicine, its route- and dose-dependent impacts on mammary oncogenesis, immunoregulation, and non-coding RNA (ncRNA) dynamics remain poorly defined. Here, female BALB/c mice bearing subcutaneous 4T1 mammary carcinomas were...